Enliven Therapeutics, Inc. (ELVN)
NASDAQ: ELVN · Real-Time Price · USD
20.68
-0.84 (-3.90%)
At close: Jun 27, 2025, 4:00 PM
20.68
0.00 (0.00%)
After-hours: Jun 27, 2025, 4:04 PM EDT

Enliven Therapeutics Statistics

Total Valuation

ELVN has a market cap or net worth of $1.22 billion. The enterprise value is $931.03 million.

Market Cap 1.22B
Enterprise Value 931.03M

Important Dates

The next estimated earnings date is Tuesday, August 12, 2025, after market close.

Earnings Date Aug 12, 2025
Ex-Dividend Date n/a

Share Statistics

ELVN has 58.99 million shares outstanding. The number of shares has increased by 18.45% in one year.

Current Share Class 58.99M
Shares Outstanding 58.99M
Shares Change (YoY) +18.45%
Shares Change (QoQ) +0.39%
Owned by Insiders (%) 4.44%
Owned by Institutions (%) 52.45%
Float 36.54M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 3.67
P/TBV Ratio 4.23
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 21.06, with a Debt / Equity ratio of 0.00.

Current Ratio 21.06
Quick Ratio 20.72
Debt / Equity 0.00
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -31.30% and return on invested capital (ROIC) is -22.71%.

Return on Equity (ROE) -31.30%
Return on Assets (ROA) -21.36%
Return on Invested Capital (ROIC) -22.71%
Return on Capital Employed (ROCE) -38.21%
Revenue Per Employee n/a
Profits Per Employee -$1.53M
Employee Count 62
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, ELVN has paid $232,000 in taxes.

Income Tax 232,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -2.36% in the last 52 weeks. The beta is 0.95, so ELVN's price volatility has been similar to the market average.

Beta (5Y) 0.95
52-Week Price Change -2.36%
50-Day Moving Average 19.21
200-Day Moving Average 22.26
Relative Strength Index (RSI) 51.58
Average Volume (20 Days) 725,913

Short Selling Information

The latest short interest is 6.62 million, so 11.22% of the outstanding shares have been sold short.

Short Interest 6.62M
Short Previous Month 6.50M
Short % of Shares Out 11.22%
Short % of Float 18.12%
Short Ratio (days to cover) 12.47

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -110.26M
Pretax Income -79.60M
Net Income -94.83M
EBITDA -109.95M
EBIT -110.26M
Earnings Per Share (EPS) -$1.93
Full Income Statement

Balance Sheet

The company has $289.56 million in cash and $667,000 in debt, giving a net cash position of $288.89 million or $4.90 per share.

Cash & Cash Equivalents 289.56M
Total Debt 667,000
Net Cash 288.89M
Net Cash Per Share $4.90
Equity (Book Value) 288.30M
Book Value Per Share 5.88
Working Capital 280.35M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$73.96 million and capital expenditures -$44,000, giving a free cash flow of -$74.00 million.

Operating Cash Flow -73.96M
Capital Expenditures -44,000
Free Cash Flow -74.00M
FCF Per Share -$1.25
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

ELVN does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -18.45%
Shareholder Yield -18.45%
Earnings Yield -7.77%
FCF Yield -6.07%

Analyst Forecast

The average price target for ELVN is $39.60, which is 91.81% higher than the current price. The consensus rating is "Strong Buy".

Price Target $39.60
Price Target Difference 91.81%
Analyst Consensus Strong Buy
Analyst Count 5
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) -5.20%
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2